Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...
A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.
Invivyd, Inc. (NASDAQ:IVVD – Get Free Report) was the recipient of unusually large options trading on Thursday. Traders ...
INVESTOR ALERT: CANADIAN INVESTORS MAY BE EXCLUDED FROM THE SHAREHOLDER SETTLEMENT WITH BARCLAYS PLC
PC, a Toronto-based law firm that focuses on representing investors in cross-border and transatlantic shareholder disputes, reminds investors that the pending shareholder class action against Barclays ...
Minera Alamos Inc. (the "Company" or "Minera Alamos") announces that it has filed an early warning report pursuant to the provisions of Canadian securities legislation (the "Early Warning Report") in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback